FHMLS IX, L.L.C.'s Net Worth

$0

Estimate Recalculated Nov 7, 2024 12:17PM EST

Who is FHMLS IX, L.L.C.?

FHMLS IX, L.L.C. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Tarsus Pharmaceuticals, Inc., Phathom Pharmaceuticals, Inc., Mirum Pharmaceuticals, Inc., and Passage BIO, Inc..

SEC CIK

FHMLS IX, L.L.C.'s CIK is 0001782791

Past Insider Trading and Trends

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Tarsus Pharmaceuticals, Inc. (TARS) Snapshot price: $30.59

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.92M
$16.00
—
1.92M
Oct 20
Form 3
—
0
—
—
0
No matching records found

Phathom Pharmaceuticals, Inc. (PHAT) Snapshot price: $17.55

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-20.00%
-1.46M
—
—
5.83M
Jun 12
Form 4
+49.33%
2.41M
$16.86
$40,575,317.00
7.28M
Oct 29
Form 3
—
0
—
—
0
No matching records found

Mirum Pharmaceuticals, Inc. (MIRM) Snapshot price: $41.12

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
3.57M
$15.00
—
3.57M
Jul 22
Form 3
—
0
—
—
0
No matching records found

Passage BIO, Inc. (PASG) Snapshot price: $0.7

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
5.01M
$18.00
—
5.01M
Mar 3
Form 3
—
0
—
—
0
No matching records found